We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-39.48%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$162M
AUM Growth
-$179M
Cap. Flow
-$11.7M
Cap. Flow %
-7.2%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
4
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$10.5M
2
KALV
KalVista Pharmaceuticals
KALV
+$629K
3
OCUL icon
Ocular Therapeutix
OCUL
+$522K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
1
DELISTED
KalVista Pharmaceuticals
KALV
$50.3M 30.98%
2,548,202
-31,288
-1% -$629K
TECX
2
Tectonic Therapeutic
TECX
$717M
$45.6M 28.05%
228,002
– –
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$27M 16.63%
1,287,227
-429,076
-25% -$10.5M
STRO icon
4
Sutro Biopharma
STRO
$353M
$16.5M 10.13%
182,454
– –
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$15M 9.23%
510,141
– –
XFOR icon
6
X4 Pharmaceuticals
XFOR
$419M
$4.34M 2.67%
10,383
– –
OCUL icon
7
Ocular Therapeutix
OCUL
$2.38B
$2.5M 1.54%
628,236
-94,700
-13% -$522K
ATXS
8
DELISTED
Astria Therapeutics
ATXS
$1.25M 0.77%
47,628
– –
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
$0 ﹤0.01%
1,072
-148,992
-99% –

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q4 2018 Portfolio in Review

As of Q4 2018, SV Health Investors held 9 positions worth $162M, down 52% from $342M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $11.7M in Q4 2018, reducing 4 holdings. Its largest reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $10.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's biggest Q4 2018 reduction was Deciphera Pharmaceuticals, Inc. Common Stock, cutting an estimated $10.5M.
  • SV Health Investors's ten largest holdings make up 100% of its $162M portfolio in Q4 2018.
  • SV Health Investors opened 0 new positions and closed 0 in Q4 2018.
  • SV Health Investors's portfolio value fell 52% quarter-over-quarter to $162M.

Based on SV Health Investors's 13F filing for Q4 2018, filed 14 Feb 2019.